CLINICAL_TRIALS
trial_result
· 2012-08-29
Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease [Phase 2]
Summary
A Phase 2 trial of istradefylline (KW-6002) for Parkinson's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED